side effects of glp 1 drugs for weight loss GLP-1 Drugs: How Semaglutide & Tirzepatide Redefine Obesity Care GLP-1 medication side effects for
Description
Study Design In the present study, researchers evaluated the association between GLP-1 agonist use and breast cancer incidence
Sattar, D

New Study Recommends Stopping GLP-1 Agonists 14 Days Before Total Joint Arthroplasty to Reduce Anesthesia Risks SAN DIEGO (March 10, 2025)Glucagon-like peptide-1 receptor agonists (GLP-1 agonists), such as semaglutide (e.g., Ozempic), have helped improve the management of type 2 diabetes and obesity

doi: 10.1016/S0167-0115(02)00039-3

Obes Rev (2022) 23(2):e13372